Pfizer (PFE)

Add to Watchlists
Create an Alert
30.09 +0.20  +0.67% NYSE Apr 16, 8:00PM BATS Real time Currency in USD

Pfizer Return on Equity (TTM):

27.77% for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Pfizer Return on Equity (TTM) Chart

Export Data
Save Image

Pfizer Historical Return on Equity (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 27.77%
Sept. 30, 2013 32.06%
June 30, 2013 32.71%
March 31, 2013 19.04%
Dec. 31, 2012 17.87%
Sept. 30, 2012 11.64%
June 30, 2012 12.08%
March 31, 2012 11.04%
Dec. 31, 2011 11.42%
Sept. 30, 2011 12.91%
June 30, 2011 9.76%
March 31, 2011 9.58%
Dec. 31, 2010 9.36%
Sept. 30, 2010 7.31%
June 30, 2010 10.31%
March 31, 2010 10.75%
Dec. 31, 2009 12.82%
Sept. 30, 2009 12.95%
June 30, 2009 11.98%
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Get data for
Advertisement

PFE Return on Equity (TTM) Benchmarks

Companies
Roche Holding 112.6%
Novartis 13.03%
Merck 8.78%

PFE Return on Equity (TTM) Range, Past 5 Years

Minimum 7.31% Sep 2010
Maximum 32.71% Jun 2013
Average 14.91%
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.